Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Dec 4, 2024
144 Dec 4, 2024
4 Nov 27, 2024
SCHEDULE 13G/A Nov 14, 2024
SCHEDULE 13G Nov 14, 2024
SC 13G Nov 14, 2024 PASSAGE BIO, INC.
10-Q Nov 13, 2024 10-Q
8-K Nov 13, 2024 8-K
8-K Oct 24, 2024 8-K
4 Oct 2, 2024
4 Oct 2, 2024
3 Oct 2, 2024
4 Sep 23, 2024
4 Sep 18, 2024
144 Sep 16, 2024
144 Sep 16, 2024
8-K Sep 16, 2024 8-K
8-K Sep 10, 2024 FORM 8-K
8-K Sep 6, 2024 8-K
SC 13D/A Aug 9, 2024 SC 13D/A
SC 13G/A Aug 9, 2024 PASSAGE BIO, INC.
3 Aug 9, 2024
10-Q Aug 8, 2024 10-Q
8-K Aug 8, 2024 8-K
8-K Aug 2, 2024 FORM 8-K
← Newer Page 5 of 18 · 442 filings Older →